Table 4. Pregnancy inflammatory marker regression analysis.
Outcome/predictors and covariates | Rho | Predictor p | Model F | Model p | Adjusted R2 |
---|---|---|---|---|---|
IL-6 | |||||
EPDS | 0.31 | NS | 1.95 | NS | 0.11 |
Sampling time | -0.45 | NS | |||
Gestational week | -0.34 | NS | |||
Pre-pregnancy BMI | 0.02 | NS | |||
IL-10 | |||||
EPDS | -0.07 | NS | 1.07 | NS | < 0.10 |
Sampling time | -0.25 | 0.05 | |||
Gestational week | -0.07 | NS | |||
Pre-pregnancy BMI | -0.11 | NS | |||
TNF-α | |||||
EPDS | -0.19 | NS | 0.30 | NS | 0.00 |
Sampling time | 0.12 | NS | |||
Gestational week | 0.07 | NS | |||
Pre-pregnancy BMI | 0.09 | NS | |||
CRP | |||||
EPDS | 0.06 | NS | 4.10 | 0.03 | 0.17 |
Pre-pregnancy BMI* | 0.48 | 0.009 |
BMI = body mass index; CRP = C-reactive protein; EPDS = Edinburgh Perinatal Depression Scale; IL-6 = interleukin-6; IL-10 = interleukin-10; NS = non-significant; TNF-α = tumor necrosis factor alpha.
Significant main effect for predictor/covariate (p ≤ 0.05).